Evaluation of the Effect of Propolis Mouthwash in the Prevention of Mucositis

Evaluation of the Effect of Propolis Mouthwash in the Prevention of the Chemotherapy Induced Mucositis

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT2016022924959N2

Enrollment

Registered

2016-03-18

Start date

2016-04-03

Completion date

Unknown

Last updated

2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

mucositis. K12.3

Interventions

Intervention group: Mouthwash Propolis (Mashhad Tak Toos Soren Co, 30% extracts) Control group: Placebo (Mashhad Tak Toos Soren Co, Water and Additives).

Prevention

Intervention group: Mouthwash Propolis (Mashhad Tak Toos Soren Co, 30% extracts) Control group: Placebo (Mashhad Tak Toos Soren Co, Water and Additives)

Eligibility

Sex/Gender

All

Age

20 Years to 60 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: Adults aged 20-60 years old; patients referred to the Hematology and Oncology Department of the Shahid Sadoughi Hospital for chemotherapy and at first courses developed mucositis. Exclusion criteria: Outside the specified age range; sensitivity to Propolis mouthwash; the worsening condition of the patient

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Ability to eat and drink. Timepoint: Seventh and fourteenth days. Method of measurement: Ask from the Patient.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMaryam Jalili Sadr Abad

Shahid Sadoughi University of Medical Sciences

hn_1364@yahoo.com+98 35 3822 9104

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026